May 2016 - Page 3 of 10 - QualityStocks

TuesdayMay 24, 2016 12:16 pm

Laguna Blends, Inc. (LAGBF) Product Passes the Flavor Test with Family and Friends of QualityStocks

Laguna Blends, Inc. (OTC: LAGBF) has a rapidly growing network of independent affiliates that includes more than 700 members from all corners of the United States and Canada. While this growth can be partially attributed to the company’s business model, which allows individuals to leverage tools and technology to build an international business from their own homes, Laguna’s innovative product line is also noteworthy. Capitalizing on the strong performance of the hemp retail industry, which was estimated at $620 million in 2014 according to the Hemp Industries Association, Caffe and Pro369 are infused with hemp protein to appeal to an…

TuesdayMay 24, 2016 8:39 am

Star Mountain Resources, Inc. (SMRS) Primed to Benefit as Goldman Sachs Raises Six-Month Zinc Price Forecast

Zinc recorded a mild decline last week as the U.S. dollar strengthened against foreign currencies, but industry analysts remain bullish regarding the metal moving forward. On Thursday, Goldman Sachs upped its six-month price forecast for zinc to $2,100 a metric ton, an increase of more than 23 percent over previous forecasts. The investment banking firm cited stronger than previously anticipated demand from China and a tightening supply stemming from mine depletions and producer discipline as primary factors in its calculation. “We view zinc as the bullish exception in the metals space, and remain very bearish on the outlook for the…

MondayMay 23, 2016 12:59 pm

Agora Holdings, Inc. (AGHI) Offers Single On-Ramp to a Multitude of Social Media Environments

Agora Holdings, Inc. (OTC: AGHI) is providing enterprises with a tool to help their investor and public relations departments control their content and message flow in today’s not-so-easy-to-navigate social media waters, and if there is one product characteristic the company is proud to hang its hat on, it is the fact that FRAME passes the ultimate litmus test for success. Just ask Facebook (NASDAQ: FB), Twitter (NYSE: TWTR) and Instagram. With literally hundreds of burgeoning social media networks clawing for mindshare, time and attention and offering their own individual access to impressive numbers of followers, FRAME delivers a comprehensive and…

MondayMay 23, 2016 9:23 am

International Stem Cell Corp. (ISCO) Teams with Leading Cryogenic Logistics Provider for Impending Clinical Trial

Before the opening bell, Cryoport, Inc. (NASDAQ: CYRX), a premier provider of cryogenic logistics solutions to the life sciences industry, announced a strategic partnership with International Stem Cell Corp. (OTCQB: ISCO) through which it will provide global logistics support to ISCO for its impending phase I clinical trial. ISCO received authorization to begin a phase I/IIa clinical trial of its human parthenogenetic stem cell-derived neural stem cells (ISC-hpNSC) in patients with moderate to severe Parkinson’s disease from the Therapeutic Goods Administration of Australia in December, and the company commenced patient enrollment for the study earlier this year. As the premier…

MondayMay 23, 2016 8:43 am

Laguna Blends Inc. (LAGBF) Offers Treasure Chest of Opportunity to Aspiring Entrepreneurs and Affiliates

Laguna Blends Inc. (OTC: LAGBF) asks, “Have you ever dreamed of owning your own business - full-time or part-time?” The very thought conjures up a multitude of emotions over a wide spectrum of aspirations and ambitions. ‘What if you could be involved in a home-based business and didn’t have to be good at sales?’ For the person who is moved to take action as a result of these questions, his or her thought process quickly and naturally turns to the obvious – ‘What product or service energizes me, and, if I can chart my own course, I may as well…

FridayMay 20, 2016 4:04 pm

International Stem Cell Corp. (ISCO) Covered in Report by Edison Investment Research

Earlier this week, Edison Investment Research, a leading independent investment intelligence firm, commenced coverage of International Stem Cell Corp. (OTCQB: ISCO). In the initial report, Edison gives prospective investors an in-depth look at ISCO’s current market position, including its impending Phase I/IIa clinical trials for the treatment of Parkinson’s disease, as well as its revenue-generating subsidiaries, Lifeline Skin Care and Lifeline Cell Technology, which Edison suggests ‘provide a floor under ISCO’s current valuation, creating an essentially free option on the PD candidate’. To view the full report, visit http://dtn.fm/fIF6B Leveraging its innovative human parthenogenetic stem cell (hpSC) technology, ISCO has…

FridayMay 20, 2016 2:36 pm

Take your NextTrip with Monaker Group (MKGI)

Monaker Group, Inc. (OTCQB: MKGI) is traveling far and fast. In a recent interview with investor relations firm MissionIR, CEO Bill Kerby recapitulated the company’s most recent achievements and its prospects in the growing online travel-booking marketplace. Statista estimates (http://dtn.fm/6rOeB) that global international tourism revenue in 2014 was $1,245 billion. Of that, about 27 percent, or $340 billion, was online travel-booking revenues. Online travel agency (OTA) revenues are expected to continue growing at 12 percent annually, according to this Forbes piece (http://dtn.fm/BIjt4). OTA websites have evolved to accommodate this increased demand and now may offer information and access to airlines,…

FridayMay 20, 2016 2:02 pm

Rennova Health, Inc. (RNVA) Enhancing Speed and Accuracy of Diagnostic Testing and Record Processing

Rennova Health, Inc. (NASDAQ: RNVA), based in West Palm Beach, Florida, specializes in providing a full range of medical and administrative technologies and services to U.S. healthcare providers. The company’s suite of products and services are designed to enhance treatment success while streamlining customer and financial information processing, improving both patient and financial outcomes. Rennova Health provider solutions include: Diagnostic Solutions – Rennova offers comprehensive clinical testing services, including advanced toxicology and esoteric lab services such as urine testing for abuse of drugs and prescription medications, in addition to bacteriology, serology, immunology, hematology and neurotransmitter testing. Brands: Medytox Diagnostics Revenue…

FridayMay 20, 2016 1:31 pm

International Stem Cell Corp. (ISCO) Introducing a New Era of Medicine with its First Phase of Clinical Trials

International Stem Cell Corporation (OTCQB: ISCO) is a biotechnology company that focuses on early-stage cell therapy. ISCO uses stem cells to treat a variety of diseases, including those of the eyes, the nervous system, and the liver, among others. The scientists at ISCO treat severe diseases with state-of-the-art technology. The aim of the company is to create therapeutic products from its own intellectual property. With this in mind, ISCO also owns two subsidiary companies. Lifeline Skin Care Inc. is a business that develops and manufactures skin care products, while Lifeline Cell Technology, LLC is a research products business that develops…

FridayMay 20, 2016 12:49 pm

Oakridge Global Energy Solutions, Inc. (OGES) Setting Its Sights on Strategic Advances

Oakridge Global Energy Solutions (OTCQB: OGES) began life as a true research and development company, and now, 30 years later, it has grown to become the developer of some of the world's best energy solutions. In that time, Oakridge has also advanced its business strategies considerably in order to become a global leader in the innovation, development, manufacturing and marketing of disruptive energy storage technology for military, civilian and medical uses. The past couple of years have been especially significant for Oakridge, with corporate milestones including: The company successfully finalized a major two-year restructuring plan at the end of 2015.…

Site Search

Company Search

Month: May 2016